Get started
Author

Хамитов Равиль Авгатович

Observed names: R. A. KHAMITOV, R. A. Khamitov, R. Khamitov, R.A. Khamitov, Ravil A. Khamitov, Ravil Khamitov, Р. А. Хамитов, Хамитов Р. A., Хамитов Р. А.
ORCID: 0000-0002-1314-894X
Observed ORCID: 0000-0002-1314-894X
OpenAlex ID: A5015374870
Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
2021 · Irina Leneva, Nadezhda Kartashova, et al. · Viruses · 47
PDF
Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit
2021 · D. A. Poteryaev, S. G. Abbasova, et al. · Biological Products Prevention Diagnosis Treatment · 15
PDF
Physico-Chemical and Biological Properties of Biosimilar and Reference Tissue Plasminogen Activator Products
2019 · V. D. Gusarova, M. S. Pantyushenko, et al. · Biological Products Prevention Diagnosis Treatment · 11
PDF
Prospects for Using the ELISPOT Technological Platform as Part of Anti-Epidemic Measures Against the New Coronavirus Infection COVID-19
2020 · D. A. Poteryaev, R. A. Khamitov, et al. · Biological Products Prevention Diagnosis Treatment · 7
PDF
Principle of Express Selection of Leading Producing Clones of Monoclonal Antibodies in the Development of Stable CHO-Based Cell Lines
2019 · V.I. Pavelko, I.A. Kirik, et al. · Biotekhnologiya · 5
Increasing productivity of arylsulfatase B-producing cell line by coexpression of formylglycine-generating enzyme
2022 · S. S. Timonova, K. A. Smolova, et al. · Biological Products Prevention Diagnosis Treatment · 4
PDF
Implementation of the quality-by-design concept for an adeno-associated viral vector-based gene therapy
2025 · D. S. Kopein, G. N. Poroshin, et al. · Biological Products Prevention Diagnosis Treatment · 3
Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III
2024 · E. V. Akatova, Yu. S. Bakhareva, et al. · Modern Rheumatology Journal · 3
PDF
A Study of the Comparability of the Pharmacodynamic, Toxicological, and Pharmacokinetic Properties of the Reference Drug Pulmozyme® and the Biosimilar Drug Tigerase®
2024 · M. S. Aksenova, E. N. Bocharova, et al. · Doklady Biochemistry and Biophysics · 3
Virus neutralizing antibodies in pseudovirus particle neutralization reaction as a bioanalytical part of a Salnavac® vaccine clinical trial
2023 · Evgeniy V. Zuev, Oksana Anatolievna Markova, et al. · Russian Journal of Infection and Immunity · 3
Design of a stable cell line producing recombinant darbepoetin alpha based on CHO cells
2014 · R. R. Shukurov, N. V. Lobanova, et al. · Applied Biochemistry and Microbiology · 3
Safety, tolerability, and pharmacokinetics of verenafusp alfa in healthy volunteers: results of an open-label multicohort phase I study
2026 · Elena A. Smolyarchuk, Susanna S. Sologova, et al. · Terapevticheskii arkhiv · 2
PDF
T-cell sensitization dynamics after intranasal and intramuscular immunization with a two-component vector vaccine for the prevention of coronavirus infection based on Ad26 and Ad5
2024 · E.V. Zuev, O.A. Markova, et al. · Immunologiya · 2
PDF
Comparative safety evaluation of intranasal and intramuscular immunisation with Ad26 and Ad5-vectored vaccines to prevent coronavirus infection
2023 · E. V. Zuev, O. L. Evdokimova, et al. · Biological Products Prevention Diagnosis Treatment · 2
PDF
An experience of scaling and intensifying the industrial production of the Gam-COVID-Vac vector adenovirus vaccine in the limiting conditions of the pandemic
2022 · A. N. Morozov, I. R. Yakhin, et al. · Biological Products Prevention Diagnosis Treatment · 2
PDF
Interim results of a multicenter, open-label, multicohort study of enzyme replacement therapy with Verenafusp Alfa in patients under 18 years of age with Mucopolysaccharidosis Type II
2026 · L.S. Namazova-Baranova, N.D. Vashakmadze, et al. · PEDIATRIA Journal named after G N SPERANSKY · 1
Метод Монте-Карло для вычисления вероятности моноклональности клеточных линий
2024 · С. С. Тимонова, В. И. Павелко, et al. · Biotekhnologiya · 1
Optimization and validation of flow cytometry method for quantification of SARS-CoV-2 antigen-reactive human memory T cells
2023 · Olga M. Strizhakova, Andrey S. Pershin, et al. · Russian Journal of Infection and Immunity · 1
PDF
Optimisation of culture conditions for a producer clone coexpressing arylsulfatase B and a formylglycine-generating enzyme in order to increase the yield of arylsulfatase B
2022 · S. S. Timonova, K. A. Smolova, et al. · Biological Products Prevention Diagnosis Treatment · 1
PDF
Evaluation of the Virus Elimination and Inactivation at Different Stages of the Model Biotechnological Process for the Production of a Drug Based on the Monoclonal Antibody Fab-Fragment
2021 · S.G. Yurkov, S.P Zhivoderov, et al. · Biotekhnologiya · 1
Reconstruction of Industrial Processes for Cultivating CHO Cells in a Scale-Down Bioreactor Model
2021 · A.N. Morozov, Z.V. Zakharov, et al. · Biotekhnologiya · 1
Valuation of an N-glycosylation profile of recombinant blood coagulation factor VIIa molecule
2020 · O.B. Ustinnikova, O.B. Rounova, et al. · Molekulyarnaya Meditsina (Molecular medicine) · 1
Methodological Approaches to Validation of Therapeutic Recombinant Proteins Production Based on the Quality by Design Concept
2018 · N. V. Stratonova, A. S. Lisov, et al. · Biological Products Prevention Diagnosis Treatment · 1
PDF
Optimization of genetic constructs for high-level expression of the darbepoetin gene in mammalian cells
2014 · R. R. Shukurov, K. Yu. Kazachenko, et al. · Applied Biochemistry and Microbiology · 1
Analytical Characterization, Pharmacokinetics, Safety, and Preliminary Immunogenicity of GNR-062, an Agalsidase Beta Biosimilar Candidate, in Healthy Male Volunteers
2026 · Ivan Lyagoskin, Maksim Smolov, et al. · BioTech
Works count: 54
Citation count: 121
H-index: 5
I10-index: 3
Year
Topic
Type